Pharmacy Daily | PSA chief steps down

THE Pharmaceutical Society of Australia (PSA) announced yesterday that its chief executive officer, Adjunct Associate Professor Steve Morris, had given notice that he is resigning (PD Breaking News).

Today will be his last day in the role, with the PSA Board appointing PSA Vice President Elect Bridget Totterman as Interim CEO "to ensure all key strategic initiatives of the PSA are brought to fruition".

The Board acknowledged Assoc Prof Morris' impact throughout his tenure with the organisation, including achievements and progress made on key strategic initiatives, membership growth, strengthened relationships with government and other stakeholders, and commitment to drive innovation in quality use of medicines and pharmacist practice.

PSA National President Assoc Prof Fei Sim said the organisation remains focused on stability and continuity as it enters the next phase of transformational growth, and thanked Assoc Prof Morris for his contribution.

"Steve has overseen and led the team at the PSA through a significant period of challenge, including major health policy changes and sector-wide reforms," she said.

"We thank Steve for the significant contribution he has made to progressing PSA's mission to advance pharmacy practice in all areas of practice, and to support pharmacists to continue to deliver excellence in healthcare to all patients."

Morris (pictured) wished the PSA well as it further enhances access to care and improves the quality use of medicines.

"During my time as CEO, I have thoroughly enjoyed being part of such a passionate and committed team during a period of challenge, growth and transformation for the organisation," he said.

"I am proud of the strides we have made in supporting the pharmacy workforce across Australia."

A recruitment process will be undertaken in the first half of 2026 to appoint a new CEO.

The tenure of Assoc Prof Fei Sim as PSA President ends this year, with Professor Mark Naunton taking the reins from Jan 2026 (PD 08 Dec).